Jooss K - Search Results

1

Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice.

Ganesh S, Gonzalez Edick M, Idamakanti N, Abramova M, Vanroey M, Robinson M, Yun CO, Jooss K. Ganesh S, et al. Among authors: jooss k. Cancer Res. 2007 May 1;67(9):4399-407. doi: 10.1158/0008-5472.CAN-06-4260. Cancer Res. 2007. PMID: 17483354 Free article.

2

Administration of IFN-alpha enhances the efficacy of a granulocyte macrophage colony stimulating factor-secreting tumor cell vaccine.

Prell RA, Li B, Lin JM, VanRoey M, Jooss K. Prell RA, et al. Among authors: jooss k. Cancer Res. 2005 Mar 15;65(6):2449-56. doi: 10.1158/0008-5472.CAN-04-1975. Cancer Res. 2005. PMID: 15781661

3

Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.

Lin J, Lalani AS, Harding TC, Gonzalez M, Wu WW, Luan B, Tu GH, Koprivnikar K, VanRoey MJ, He Y, Alitalo K, Jooss K. Lin J, et al. Among authors: jooss k. Cancer Res. 2005 Aug 1;65(15):6901-9. doi: 10.1158/0008-5472.CAN-05-0408. Cancer Res. 2005. PMID: 16061674

4

Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models.

Ganesh S, Gonzalez-Edick M, Gibbons D, Van Roey M, Jooss K. Ganesh S, et al. Among authors: jooss k. Clin Cancer Res. 2008 Jun 15;14(12):3933-41. doi: 10.1158/1078-0432.CCR-07-4732. Clin Cancer Res. 2008. PMID: 18559615

5

Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.

Ganesh S, Gonzalez-Edick M, Gibbons D, Waugh J, Van Roey M, Jooss K. Ganesh S, et al. Among authors: jooss k. Hum Gene Ther. 2009 Oct;20(10):1201-13. doi: 10.1089/hum.2009.045. Hum Gene Ther. 2009. PMID: 19572803

6

Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer.

Ganesh S, Gonzalez-Edick M, Gibbons D, Ge Y, VanRoey M, Robinson M, Jooss K. Ganesh S, et al. Among authors: jooss k. Cancer Gene Ther. 2009 May;16(5):383-92. doi: 10.1038/cgt.2008.90. Epub 2008 Nov 14. Cancer Gene Ther. 2009. PMID: 19011598

7

Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors.

Harding TC, Dickinson PJ, Roberts BN, Yendluri S, Gonzalez-Edick M, Lecouteur RA, Jooss KU. Harding TC, et al. Hum Gene Ther. 2006 Aug;17(8):807-20. doi: 10.1089/hum.2006.17.807. Hum Gene Ther. 2006. PMID: 16942441

8

Rapamycin-regulated control of antiangiogenic tumor therapy following rAAV-mediated gene transfer.

Nguyen M, Huan-Tu G, Gonzalez-Edick M, Rivera VM, Clackson T, Jooss KU, Harding TC. Nguyen M, et al. Mol Ther. 2007 May;15(5):912-20. doi: 10.1038/mt.sj.6300079. Epub 2007 Jan 23. Mol Ther. 2007. PMID: 17245354 Free article.

9

Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy.

Nguyen MC, Tu GH, Koprivnikar KE, Gonzalez-Edick M, Jooss KU, Harding TC. Nguyen MC, et al. Cancer Immunol Immunother. 2010 Sep;59(9):1313-23. doi: 10.1007/s00262-010-0858-5. Epub 2010 May 25. Cancer Immunol Immunother. 2010. PMID: 20499060 Free PMC article.

10

Stable antibody expression at therapeutic levels using the 2A peptide.

Fang J, Qian JJ, Yi S, Harding TC, Tu GH, VanRoey M, Jooss K. Fang J, et al. Among authors: jooss k. Nat Biotechnol. 2005 May;23(5):584-90. doi: 10.1038/nbt1087. Epub 2005 Apr 17. Nat Biotechnol. 2005. PMID: 15834403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters